Evidence map›Paper›PMID 31691120›Full record

ArticleEuropean radiology2020

Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods.

A de Sitter, M Visser, I Brouwer, K S Cover, R A van Schijndel, R S Eijgelaar, D M J Müller, S Ropele, L Kappos, Á Rovira and 11 more

Abstract read
In one paragraph

Article in European radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Defacing biases visual quality assessments of structural MRI.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Implementation and validation of face de-identification (de-facing) in ADNI4.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Reproducibility evaluation of the effects of MRI defacing on brain segmentation.Journal of medical imaging (Bellingham, Wash.) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

A de SitterDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands. A.deSitter@vumc.nl.ORCID http://orcid.org/0000-0003-2579-9675
M VisserDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
I BrouwerDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
K S CoverDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
R A van SchijndelDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
R S EijgelaarDepartment of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
D M J MüllerDepartment of Neurosurgery, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
S RopeleDepartment of Neurology, Medical University of Graz, Graz, Austria.
L KapposDepartment of Neurology, University Hospital, Kantonsspital, Basel, Switzerland.
Á RoviraUnitat de Ressonància Magnètica (Servei de Radiologia), Hospital universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
M FilippiNeuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, UniSR, Milan, Italy.
C EnzingerDivision of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.
J FrederiksenDepartment of Neurology, Glostrup University Hospital, Copenhagen, Denmark.
O CiccarelliUK/NIHR UCL-UCLH Biomedical Research Centre, Institute of Neurology, UCL, London, UK.
C R G GuttmannCenter for Neurological Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
M P WattjesDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
M G WitteDepartment of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
P C de Witt HamerDepartment of Neurosurgery, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
F BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
H VrenkenDepartment of Radiology and Nuclear Medicine, Amsterdam Neuroscience Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
MAGNIMS Study Group and Alzheimer’s Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
KWF Kankerbestrijding VU2014-7113Medical Devices Initiative as part of NWO, NL 10-10400-96-14003NIA NIH HHS U01 AG024904NIHR Biomedical Research Centre nanNIHR Biomedical Research Centre at UCLH nanStichting MS Research 09-358dStichting MS Research 14-358e
6 · The paper itself

Abstract

backgroundRecent studies have created awareness that facial features can be reconstructed from high-resolution MRI. Therefore, data sharing in neuroimaging requires special attention to protect participants' privacy. Facial features removal (FFR) could alleviate these concerns. We assessed the impact of three FFR methods on subsequent automated image analysis to obtain clinically relevant outcome measurements in three clinical groups.

methodsFFR was performed using QuickShear, FaceMasking, and Defacing. In 110 subjects of Alzheimer's Disease Neuroimaging Initiative, normalized brain volumes (NBV) were measured by SIENAX. In 70 multiple sclerosis patients of the MAGNIMS Study Group, lesion volumes (WMLV) were measured by lesion prediction algorithm in lesion segmentation toolbox. In 84 glioblastoma patients of the PICTURE Study Group, tumor volumes (GBV) were measured by BraTumIA. Failed analyses on FFR-processed images were recorded. Only cases in which all image analyses completed successfully were analyzed. Differences between outcomes obtained from FFR-processed and full images were assessed, by quantifying the intra-class correlation coefficient (ICC) for absolute agreement and by testing for systematic differences using paired t tests.

resultsAutomated analysis methods failed in 0-19% of cases in FFR-processed images versus 0-2% of cases in full images. ICC for absolute agreement ranged from 0.312 (GBV after FaceMasking) to 0.998 (WMLV after Defacing). FaceMasking yielded higher NBV (p = 0.003) and WMLV (p ≤ 0.001). GBV was lower after QuickShear and Defacing (both p < 0.001).

conclusionsAll three outcome measures were affected differently by FFR, including failure of analysis methods and both "random" variation and systematic differences. Further study is warranted to ensure high-quality neuroimaging research while protecting participants' privacy. KEY POINTS: • Protecting participants' privacy when sharing MRI data is important. • Impact of three facial features removal methods on subsequent analysis was assessed in three clinical groups. • Removing facial features degrades performance of image analysis methods.

Indexed as

ConfidentialityAgedAged, 80 and overAlgorithmsAlzheimer DiseaseBrainFaceFemaleGlioblastomaHumansImage Interpretation, Computer-AssistedInformation DisseminationMagnetic Resonance ImagingMaleMiddle AgedMultiple SclerosisDatabaseEthicsMagnetic resonance imagingNeuroimagingPrivacy

Identifiers

PMID31691120
PMCPMC6957560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.